Scopolamine Patch
Product Images NDC 0378-6470

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 0378-6470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Scopolamine Transdermal System 1 mg/3 Days (Image 01)

Scopolamine Transdermal System 1 mg/3 days packaging label from Mylan Pharmaceuticals Inc. The carton contains 4 transdermal systems. The label details dosage form as a patch for transdermal use, highlights protection instructions, dosage and administration steps, and cautions about drowsiness and blurred vision. It also notes that the product is Rx only and provides contact information for the manufacturer.*

FDA Label Image

Scopolamine Structural Formula (Image 02)

Chemical structure of scopolamine showing its molecular framework with characteristic rings and functional groups, including a methylated nitrogen and an ester moiety.*

FDA Label Image

Cross Section Of The System (Image 03)

An instructional diagram illustrating the layered structure of a transdermal patch. The layers from top to bottom are labeled as Backing Layer, Solid Matrix Drug Reservoir, Membrane, Adhesive Formulation, and Protective Release Liner.*

FDA Label Image

Instructions For Use Figure 1 (Image 04)

An instructional diagram of a Scopolamine transdermal patch showing its components: a clear disposable release liner, an adhesive surface, and a peach backing membrane imprinted with "Scopolamine 1 mg / 3 days." The patch is depicted within a square outline.*

FDA Label Image

Instructions For Use Figure 2 (Image 05)

An instructional illustration showing how to open the Scopolamine transdermal patch pouch by tearing along the dashed line. The diagram includes an outlined pouch with a tear notch and directional text to aid proper pouch opening.*

FDA Label Image

Instructions For Use Figure 3 (Image 06)

An instructional illustration labeled Figure 3 showing both hands peeling apart a protective backing from a scopolamine transdermal patch. The image visually guides the user on how to remove the patch backing before application.*

FDA Label Image

Instructions For Use Figure 4 (Image 07)

An instructional diagram showing hands holding a scopolamine transdermal patch. The diagram labels the patch components including an imprinted, peach-colored transdermal system, the adhesive surface, and a clear, disposable release liner. This illustration is likely intended to guide proper patch handling or application.*

FDA Label Image

Instructions For Use Figure 5 (Image 08)

An illustration showing the placement of a peach-colored, imprinted transdermal system patch behind the ear on the side of the head. The diagram highlights the patch location for Scopolamine transdermal administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.